日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial

帕博利珠单抗辅助治疗完全切除的 I 期肺腺癌（微乳头状或实性组织学亚型）：一项单中心、单臂 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103282
Kim, Jhingook; Bang, Yeong Hak; Park, Sehhoon; Jung, Hyun-Ae; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Jeon, Yeong Jeong; Lee, Junghee; Cho, Jong Ho; Kim, Hong Kwan; Choi, Yong Soo; Zo, Jae Ill; Shim, Young Mog; Kang, Jung Hee; Lee, Jinseon; Choi, Yoon-La; Han, Joungho; Hwang, Soohyun; Lee, Ho Yun; Lee, Se-Hoon
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy of contrast versus non-contrast CT surveillance among patients surviving two years without recurrence after surgery for stage I lung cancer

对比增强CT与非增强CT监测在I期肺癌手术后两年无复发生存患者中的疗效

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-90124-x
Jeon, Yeong Jeong; Kang, Danbee; Lee, Junghee; Park, Seong Yong; Cho, Jong Ho; Choi, Yong Soo; Kim, Jhingook; Shim, Young Mog; Lee, Ho Yun; Cho, Juhee; Kim, Hong Kwan
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Impact of tumor size by clinical N subclassification and histology in trimodality-treated N2 non-small cell lung cancer

肿瘤大小对接受三联疗法治疗的N2期非小细胞肺癌的影响（临床N分期和组织学分级）

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-82946-y
Lee, Junghee; Lee, Jin; Hong, Yun Soo; Lee, Genehee; Park, Jiyoun; Jeon, Yeong Jeong; Park, Seong-Yong; Cho, Jong Ho; Choi, Yong Soo; Kim, Jhingook; Shim, Young Mog; Guallar, Eliseo; Cho, Juhee; Kim, Hong Kwan
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Enhancing Identification of High-Risk cN0 Lung Adenocarcinoma Patients Using MRI-Based Radiomic Features

利用基于MRI的放射组学特征增强对高危cN0期肺腺癌患者的识别

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.251
Kim, Harim; Kim, Jonghoon; Hwang, Soohyun; Oh, You Jin; Ahn, Joong Hyun; Kim, Min-Ji; Hong, Tae Hee; Park, Sung Goo; Choi, Joon Young; Kim, Hong Kwan; Kim, Jhingook; Shin, Sumin; Lee, Ho Yun
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Response to: Histological type, invasive mediastinal staging, and prognosis in patients with lung cancer

回复：肺癌患者的组织学类型、侵袭性纵隔分期和预后

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102644
Jeon, Yeong Jeong; Kim, Hong Kwan; Hwang, Seung-Sik; Kim, Jhingook
肺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study

纵隔淋巴结侵入性分期在无放射学淋巴结转移的非小细胞肺癌患者生存结局中的作用：一项回顾性队列研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102478
Kim, Hong Kwan; Jeon, Yeong Jeong; Um, Sang-Won; Shin, Sun Hye; Jeong, Byeong-Ho; Lee, Kyungjong; Kim, Hojoong; Lee, Ho Yun; Kim, Tae Jung; Lee, Kyung Soo; Choi, Yoon-La; Han, Joungho; Ahn, Yong Chan; Pyo, Hongryull; Noh, Jae Myoung; Choi, Joon Young; Cho, Jong Ho; Choi, Yong Soo; Zo, Jae Ill; Shim, Young Mog; Hwang, Seung-Sik; Kim, Jhingook
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer

综合分析小细胞肺癌转录因子的分子亚型及其与临床结果的相关性

期刊:EBioMedicine
影响因子:9.7
doi:10.1016/j.ebiom.2024.105062
Sehhoon Park, Tae Hee Hong, Soohyun Hwang, Simon Heeke, Carl M Gay, Jiyeon Kim, Hyun-Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Jong Ho Cho, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Hong Kwan Kim, Lauren Averett Byers, John V Heymach, Yoon-La Choi, Se-Hoon Lee, Keunchil Park
肿瘤
肺癌
其它细胞
发表日期：2024
文献求助 收藏

Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer

新型等位基因鉴别引物系统技术在可手术非小细胞肺癌患者中对EGFR突变检测的超高灵敏度进行临床验证

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2023.408
Park, Il-Hyun; Son, Dae-Soon; Choi, Yoon-La; Choi, Ji-Hyeon; Park, Ji-Eun; Jeon, Yeong Jeong; Cho, Minseob; Kim, Hong Kwan; Choi, Yong Soo; Shim, Young Mog; Kang, Jung Hee; Park, Suzy; Lee, Jinseon; Kim, Sung-Hyun; Lee, Byung-Chul; Kim, Jhingook
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial

新辅助同步放化疗后完全切除的IIIA/N2期非小细胞肺癌患者接受辅助帕博利珠单抗治疗：一项前瞻性、开放标签、单臂II期试验

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.084
Shin, Junghoon; Park, Sehhoon; Kim, Kyung Hwan; Shin, Eui-Cheol; Jung, Hyun Ae; Cho, Jong Ho; Sun, Jong-Mu; Lee, Se-Hoon; Choi, Yong Soo; Ahn, Jin Seok; Kim, Jhingook; Park, Keunchil; Shim, Young Mog; Kim, Hong Kwan; Noh, Jae Myoung; Ahn, Yong Chan; Pyo, Hongryull; Ahn, Myung-Ju
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Outcomes of Completion Lobectomy for Locoregional Recurrence after Sublobar Resection in Patients with Non-small Cell Lung Cancer

非小细胞肺癌患者行肺段切除术后局部区域复发行肺叶切除术的疗效

期刊:Journal of Chest Surgery
影响因子:1
doi:10.5090/jcs.23.121
Lee, Cho Eun; Yun, Jeonghee; Jeon, Yeong Jeong; Lee, Junghee; Park, Seong Yong; Cho, Jong Ho; Kim, Hong Kwan; Choi, Yong Soo; Kim, Jhingook; Shim, Young Mog
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏